MétaCan
Menu
Back to cohort
Record W4390062445 · doi:10.1093/bjd/ljad497

How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users’ guide

2023· article· en· W4390062445 on OpenAlexfundno aff
Kim S Thomas, Laura Howells, Yael A. Leshem, Eric L. Simpson, Christian Apfelbacher, Phyllis I. Spuls, Louise A. A. Gerbens, M. E. Jacobson, Norito Katoh, Hywel C Williams, Beth Stuart

Bibliographic record

VenueBritish Journal of Dermatology · 2023
Typearticle
Languageen
FieldMedicine
TopicDermatology and Skin Diseases
Canadian institutionsnot available
FundersEli Lilly JapanMitsubishi Tanabe Pharma CorporationGenentechNational Jewish HealthTorii PharmaceuticalUniversity of OxfordTaiho PharmaceuticalKyowa Kirin Pharmaceutical DevelopmentBoehringer Ingelheim JapanLEO PharmaCastle BiosciencesSun PharmaDermiraPfizerIncyteRegeneron PharmaceuticalsAmgenCelgeneValeant Pharmaceuticals InternationalSanofiGaldermaEli Lilly and CompanyBristol-Myers SquibbGlaxoSmithKline
KeywordsOutcome (game theory)Clinical trialAtopic dermatitisMedicineSet (abstract data type)Alternative medicineSample (material)MEDLINESample size determinationFamily medicineMedical physicsCore (optical fiber)Medical educationComputer scienceDermatologyStatisticsPathology

Abstract

fetched live from OpenAlex

BACKGROUND: The Harmonising Outcome Measures for Eczema (HOME) initiative has agreed upon the Core Outcome Set (COS) for use in atopic dermatitis (AD) clinical trials, but additional guidance is needed to maximize its uptake. OBJECTIVES: To provide answers to some of the commonly asked questions about using the HOME COS; to provide data to help with the interpretation of trial results; and to support sample size calculations for future trials. METHODS AND RESULTS: We provide practical guidance on the use of the HOME COS for investigators planning clinical trials in patients with AD. It answers some of the common questions about using the HOME COS, how to access the outcome measurement instruments, what training/resources are needed to use them appropriately and clarifies when the COS is applicable. We also provide exemplar data to inform sample size calculations for eczema trials and encourage standardized data collection and reporting of the COS. CONCLUSIONS: By encouraging adoption of the COS and facilitating consistent reporting of outcome data, it is hoped that the results of eczema trials will be more comprehensive and readily combined in meta-analyses and that patient care will subsequently be improved.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.150
metaresearch head score (Gemma)0.368
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Methods · Consensus signal: Methods
Teacher disagreement score0.150
Threshold uncertainty score0.793

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1500.368
Meta-epidemiology (narrow)0.0040.005
Meta-epidemiology (broad)0.0070.011
Bibliometrics0.0130.013
Science and technology studies0.0010.002
Scholarly communication0.0090.007
Open science0.0060.005
Research integrity0.0070.010
Insufficient payload (model declined to judge)0.0930.057

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.265
GPT teacher head0.413
Teacher spread0.148 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueBritish Journal of DermatologySame topicDermatology and Skin DiseasesFrench-language works237,207